Q1 Earnings Updates - Part I
Q1 earnings season is underway, with five portfolio companies reporting results. This update spotlights Cipher Pharmaceuticals (CPH.TO) and Ascent Industries (ACNT) while acknowledging three undisclosed holdings. The brief highlights early performance trends and hints at possible strategic adjustments for the fund’s investors.
Quick and Timely Idea: Positioned for a Sale
The firm announced a strategic alternatives review after previously turning down a private‑equity buyout offer. The language of the release suggests the sale process is already well‑advanced, with analysts estimating an over‑80% chance of a transaction within the next three...
30% Levered FCF Yield but Bad Balance Sheet, Bad Business?
The company, a commodity‑focused firm, projects 2026 EBITDA of $160 million, essentially flat with its 2023 $162 million level, yet its market cap does not reflect this earnings power. Management expects cash flow and announced asset sales to repair a strained balance...